TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15598919

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator (ICD) or combined cardiac resynchronization therapy and defibrillator (CRT-D)
Number of subjects: 2146

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator (ICD)
Number of subjects: 2146

Group type: EXPERIMENTAL
Intervention: All trials combined (ICD therapy)
Number of subjects: 2146
Study: 11307470

Group type: EXPERIMENTAL
Intervention: Zinc oxide and eugenol sealer (Fill Canal)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Glass ionomer sealer (Ketac‐Endo)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Epoxy resin sealer (AH Plus)
Number of subjects: 99
Study: 10021718

Group type: EXPERIMENTAL
Intervention: 200 mg/kg porcine surfactant (Group A)
Number of subjects: 165

Group type: COMPARATOR
Intervention: 100 mg/kg porcine surfactant (Group B)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: 200 mg/kg porcine surfactant (Group A) in subgroup < 1500 grams
Number of subjects: 165

Group type: COMPARATOR
Intervention: 100 mg/kg porcine surfactant (Group B) in subgroup < 1500 grams
Number of subjects: 165
Study: 8402378

Group type: EXPERIMENTAL
Intervention: Interactive videodisc (IVD) instruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional instruction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of IVD and traditional instruction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Traditional-lecture presentation first, followed by IVD instruction
Number of subjects: 0
Study: 3490270

Group type: EXPERIMENTAL
Intervention: Continuous infusion of propofol during nitrous oxide anaesthesia
Number of subjects: 57
Study: 29530781

Group type: EXPERIMENTAL
Intervention: NEI VFQ-25 composite score
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: NEI VFQ-25 near activity score
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: NEI VFQ-25 distance activity score
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Baseline NEI VFQ-25 composite score
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Baseline NEI VFQ-25 near activities score
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Baseline NEI VFQ-25 distance activities score
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Baseline mean NEI VFQ-25 scores
Number of subjects: 100
Study: 27585768

Group type: EXPERIMENTAL
Intervention: Vacuum‐formed retainer (Essix Ace plastic)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Bonded retainer (0.0175 coaxial archwire bonded with Transbond LR)
Number of subjects: 82
Study: 25626738

Group type: EXPERIMENTAL
Intervention: Sevoflurane anaesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Total intravenous anaesthesia (TIVA) with propofol/remifentanil
Number of subjects: 0
Study: 24337423

Group type: EXPERIMENTAL
Intervention: Interdisciplinary functional restoration treatment with cognitive behavior therapy
Number of subjects: 681
Study: 20486333

Group type: EXPERIMENTAL
Intervention: European D pteronyssinus extracts (3 extracts)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Mexican D pteronyssinus extract
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: US-Mexican D pteronyssinus extract
Number of subjects: 19

Group type: COMPARATOR
Intervention: Reference extract (FDA-approved extract)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: European extracts
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Mexican extract
Number of subjects: 19
Study: 18852547

Group type: EXPERIMENTAL
Intervention: High-velocity high-power training (POW)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Traditional slow-velocity progressive resistance training (STR)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group of lower extremity stretching (CON)
Number of subjects: 57
Study: 16740371

Group type: EXPERIMENTAL
Intervention: GnRH agonist therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: MRgFUS without pre-treatment
Number of subjects: 50
Study: 12924676

Group type: EXPERIMENTAL
Intervention: Imaginal Exposure with Cognitive Restructuring (IE/CR)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Imaginal Exposure (IE)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Supportive Counseling (SC)
Number of subjects: 58
Study: 9915271

Group type: EXPERIMENTAL
Intervention: 1.0 mmol/L dialysate calcium solution
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 1.25 mmol/L dialysate calcium solution
Number of subjects: 13
Study: 8525396

Group type: EXPERIMENTAL
Intervention: Praziquantel (25mg/kg body weight in one dose)
Number of subjects: 31
Study: 2305760

Group type: EXPERIMENTAL
Intervention: Successful transplantation (cyclosporine/prednisone therapy, N = 51)
Number of subjects: 766

Group type: COMPARATOR
Intervention: Successful transplantation (conventional immunosuppressive therapy; antilymphocyte globulin/prednisone/azathioprine, N = 40)
Number of subjects: 766

Group type: COMPARATOR
Intervention: Center hemodialysis
Number of subjects: 766

Group type: COMPARATOR
Intervention: Continuous ambulatory peritoneal dialysis (CAPD)
Number of subjects: 766
Study: 7023415

Group type: EXPERIMENTAL
Intervention: Men's group treatment for erectile dysfunction
Number of subjects: 21

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 21
Study: 30344863

Group type: EXPERIMENTAL
Intervention: Problem-solving training sessions (4 sessions)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 257
Study: 26929110

Group type: EXPERIMENTAL
Intervention: Lorazepam 2.5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25317790

Group type: EXPERIMENTAL
Intervention: Ibuprofen 10 mg/kg, followed by 5 mg/kg after 24 and 48 hours
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo (5% glucose)
Number of subjects: 2
Study: 22638934

Group type: COMPARATOR
Intervention: Short-course radiotherapy (SC-RT) 29 Gy in 10 twice daily fractions followed by immediate surgery; n=108
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Long-course radiochemotherapy (LC-RCHT) 54 Gy in 28 fractions with simultaneous 5-fluorouracil (5-FU) ± oxaliplatin chemotherapy followed by delayed surgery; n=117
Number of subjects: 225

Group type: COMPARATOR
Intervention: Long-course radiochemotherapy (LC-RCHT)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (SC-RT)
Number of subjects: 225
Study: 20375695

Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF) after failed EndoCinch gastroplication
Number of subjects: 11
Study: 17084393

Group type: EXPERIMENTAL
Intervention: GnRH‐agonist/rFSH
Number of subjects: 73

Group type: COMPARATOR
Intervention: GnRH‐antagonist/rFSH
Number of subjects: 73
Study: 16186521

Group type: EXPERIMENTAL
Intervention: Simulator-based training
Number of subjects: 83

Group type: COMPARATOR
Intervention: Driving-related cognitive tasks (Control)
Number of subjects: 83
Study: 12394603

Group type: EXPERIMENTAL
Intervention: Cuffed tunneled hemodialysis catheters
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Catheter replacement or intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 10921042

Group type: COMPARATOR
Intervention: TACE
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: TACE combined with ITLE
Number of subjects: 102
Study: 8207601

Group type: EXPERIMENTAL
Intervention: Intracordal injection therapy with atelocollagen (submucosal injection)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intracordal injection therapy with atelocollagen (intramuscular injection)
Number of subjects: 20
Study: 2563321

Group type: EXPERIMENTAL
Intervention: 15 mg pirbuterol thrice daily
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (identical-appearing)
Number of subjects: 11
Study: 4607845

Group type: EXPERIMENTAL
Intervention: Ancrod therapy
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control (no therapy)
Number of subjects: 49
Study: 29855660

Group type: EXPERIMENTAL
Intervention: 4-fluoroamphetamine (100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 27993758

Group type: EXPERIMENTAL
Intervention: BMSmod (bare metal cobalt‐chromium stent with an active surface oxide layer modification)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: BMSmod
Number of subjects: 31
Study: 26020389

Group type: EXPERIMENTAL
Intervention: ETView VivaSight SL
Number of subjects: 107

Group type: COMPARATOR
Intervention: Macintosh laryngoscope (MAC)
Number of subjects: 107
Study: 23950589

Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 40
Study: 23391831

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) plus 0.5% AZM gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) only
Number of subjects: 30
Study: 19663110

Group type: EXPERIMENTAL
Intervention: Oligopeptide (Lumixyl) 0.01% w/w, applied twice daily for 16 weeks
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo (not specified)
Number of subjects: 5
Study: 16699358

Group type: EXPERIMENTAL
Intervention: Brief education and counseling intervention delivered by a nurse
Number of subjects: 3500

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 3500
Study: 14724157

Group type: EXPERIMENTAL
Intervention: Synbiotic therapy (Lactobacillus acidophilus La5, Bifidobacterium lactis Bb‐12, Streptococcus thermophilus, Lactobacillus bulgaricus, and oligofructose)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo (placebo capsules and sucrose powder)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Synbiotic therapy
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study: 11752509

Group type: EXPERIMENTAL
Intervention: Portable radiometer (Cyclops)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Thermal imager (Starsight)
Number of subjects: 37
Study: 9031265

Group type: EXPERIMENTAL
Intervention: Donor-specific transfusion (DST)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no DST)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Donor-specific transfusion (DST) in hyperresponder patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no DST) in hyperresponder patients
Number of subjects: 30
Study: 8582091

Group type: EXPERIMENTAL
Intervention: Garlic extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Garlic extract (in vitro)
Number of subjects: 0
Study: 2549261

Group type: EXPERIMENTAL
Intervention: 4 g of ascorbic acid (vitamin C)/day plus 400 mg of alpha‐tocopherol (vitamin E)/day plus 22.5 g/day of grain fiber supplement
Number of subjects: 58

Group type: COMPARATOR
Intervention: 4 g of ascorbic acid (vitamin C)/day plus 400 mg of alpha‐tocopherol (vitamin E)/day alone
Number of subjects: 58
Study: 781235

Group type: EXPERIMENTAL
Intervention: Fenoprofen
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 28315149

Group type: EXPERIMENTAL
Intervention: Myofunctional therapy (MT)
Number of subjects: 54
Study: 24843060

Group type: EXPERIMENTAL
Intervention: 10 µg Engerix‐B
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20 µg Engerix‐B
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline (no challenge dose)
Number of subjects: 0
Study: 22670051

Group type: EXPERIMENTAL
Intervention: Atrial tachyarrhythmias
Number of subjects: 2580
Study: 20146702

Group type: EXPERIMENTAL
Intervention: Omeprazole-Mg 20.6 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lansoprazole 15 mg
Number of subjects: 40
Study: 18434902

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (50 mg single bolus)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (50 mg every 6 hrs) plus Fludrocortisone (50 microg daily)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Patients with normal adrenal function (control group)
Number of subjects: 75
Study: 16215921

Group type: EXPERIMENTAL
Intervention: Philips FAST pulse oximeter
Number of subjects: 36

Group type: COMPARATOR
Intervention: Masimo SET pulse oximeter
Number of subjects: 36
Study: 12022525

Group type: EXPERIMENTAL
Intervention: Intracoronary shunt
Number of subjects: 40

Group type: COMPARATOR
Intervention: Proximal coronary artery occluded by a soft snare
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups during grafting of the posterior descending coronary artery
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups during grafting of the circumflex coronary artery
Number of subjects: 40
Study: 10335903

Group type: EXPERIMENTAL
Intervention: Troglitazone 200 mg per day
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Troglitazone 600 mg per day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 7828379

Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin‐3 (rhIL‐3) 2.5 micrograms/kg/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin‐3 (rhIL‐3) 5.0 micrograms/kg/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin‐3 (rhIL‐3) 7.5 micrograms/kg/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin‐3 (rhIL‐3)
Number of subjects: 18
Study: 2165888

Group type: EXPERIMENTAL
Intervention: Basal diet with isocaloric addition of 1 g of meat protein day‐1 kg‐1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Basal diet with addition of 170 mmol of sodium chloride/day
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Basal diet with both additions (protein and sodium)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Basal diet (control)
Number of subjects: 8
Study: 373735

Group type: EXPERIMENTAL
Intervention: Cervical manipulation performed by a medical practitioner or physiotherapist
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Cervical manipulation performed by a chiropractor
Number of subjects: 85

Group type: COMPARATOR
Intervention: Mobilization performed by a medical practitioner or physiotherapist (Control)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Cervical manipulation (Chiropractor)
Number of subjects: 85
Study: 31573935

Group type: EXPERIMENTAL
Intervention: Mobile text messaging intervention
Number of subjects: 4378

Group type: COMPARATOR
Intervention: Email intervention
Number of subjects: 4378
Study: 27345629

Group type: EXPERIMENTAL
Intervention: Folk recreation program (40 to 50 minutes, 3 times a week for 16 weeks)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 48
Study: 26082974

Group type: EXPERIMENTAL
Intervention: Adjunct minocycline (100 mg oral capsule twice daily; n = 29)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Adjunct minocycline
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (n = 23)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 23071082

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) - 2 sessions
Number of subjects: 212

Group type: COMPARATOR
Intervention: No motivational interviewing (Control group)
Number of subjects: 212
Study: 21730224

Group type: EXPERIMENTAL
Intervention: 2 g/d of plant sterols (PS)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control (without plant sterols)
Number of subjects: 82
Study: 19054288

Group type: EXPERIMENTAL
Intervention: Occlusal appliance treatment
Number of subjects: 39
Study: 16739842

Group type: EXPERIMENTAL
Intervention: Jingjin therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nimodipine (control)
Number of subjects: 100
Study: 15589061

Group type: EXPERIMENTAL
Intervention: Allopurinol 100 mg three times a day for 14 days
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Allopurinol and Placebo
Number of subjects: 41
Study: 11395699

Group type: EXPERIMENTAL
Intervention: Twin-block appliance with labial bow (TB1)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Twin-block appliance with high-pull headgear and torquing spurs (TB2)
Number of subjects: 63
Study: 9422898

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 60 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dextromethorphan 120 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Number of subjects: 24
Study: 8280549

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no electroacupuncture)
Number of subjects: 50
Study: 3544782

Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment (streptokinase) for anterior AMI
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment (streptokinase) for anterior AMI with Q waves
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment (streptokinase) for anterior AMI with high ST elevation
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment for inferior AMI
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment for inferior AMI with high ST-segment elevation
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment for inferior AMI with marked contralateral ST-segment depression
Number of subjects: 488

Group type: COMPARATOR
Intervention: Conventional treatment for anterior AMI
Number of subjects: 488

Group type: COMPARATOR
Intervention: Conventional treatment for inferior AMI
Number of subjects: 488
Study: 31679738

Group type: EXPERIMENTAL
Intervention: Single-use duodenoscope
Number of subjects: 6

Group type: COMPARATOR
Intervention: Reusable duodenoscopes
Number of subjects: 6
Study: 29588314

Group type: EXPERIMENTAL
Intervention: Active therapy
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Recurrent-event methods
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Time-to-first methods
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Cox model
Number of subjects: 4000
Study: 27049908

Group type: EXPERIMENTAL
Intervention: Immediate weight‐bearing‐as‐tolerated (WBAT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Non‐weight‐bearing for the first 6 postoperative weeks (NWB)
Number of subjects: 88
Study: 24323062

Group type: COMPARATOR
Intervention: Normal saline (0.9% sodium chloride) solution
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Normal saline (0.9% sodium chloride) solution with added gentamicin (80 mg/L)
Number of subjects: 360
Study: 22871888

Group type: EXPERIMENTAL
Intervention: β-blocker
Number of subjects: 4396

Group type: EXPERIMENTAL
Intervention: Diuretic
Number of subjects: 4396

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4396

Group type: EXPERIMENTAL
Intervention: Variability in SBP
Number of subjects: 4396

Group type: EXPERIMENTAL
Intervention: Highest measured value of SBP
Number of subjects: 4396

Group type: EXPERIMENTAL
Intervention: Variability in SBP for CHD
Number of subjects: 4396
Study: 20417857

Group type: EXPERIMENTAL
Intervention: Pyronaridine-artesunate (180 mg pyronaridine and 60 mg artesunate once a day for 3 days)
Number of subjects: 1272

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (20 mg artemether and 120 mg lumefantrine twice a day for 3 days)
Number of subjects: 1272

Group type: EXPERIMENTAL
Intervention: Pyronaridine-artesunate
Number of subjects: 1272

Group type: COMPARATOR
Intervention: Artemether-lumefantrine
Number of subjects: 1272
Study: 18242616

Group type: EXPERIMENTAL
Intervention: Fenofibrate (160mg/d)
Number of subjects: 55
Study: 16129744

Group type: EXPERIMENTAL
Intervention: Acetabular cement pressurisation for 60 seconds before insertion of the acetabular component
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acetabular cement pressurisation with simultaneous vacuum suction of the ilium
Number of subjects: 40
Study: 12609701

Group type: EXPERIMENTAL
Intervention: Feedback condition (personalized feedback and encouragement)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 73
Study: 11236340

Group type: EXPERIMENTAL
Intervention: Single dose of piperacillin sodium (2 g i.v. after umbilical cord clamping)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Triple doses of piperacillin sodium (2 g i.v. at 6 hourly intervals starting from umbilical cord clamping)
Number of subjects: 206
Study: 8861689

Group type: EXPERIMENTAL
Intervention: One-arm cranking
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Two-arm cranking
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Two-leg cycling
Number of subjects: 19
Study: 1739017

Group type: EXPERIMENTAL
Intervention: iohexol 300
Number of subjects: 600

Group type: COMPARATOR
Intervention: diatrizoate meglumine 60
Number of subjects: 600
Study: 6439064

Group type: EXPERIMENTAL
Intervention: Preoperative biliary decompression
Number of subjects: 10

Group type: COMPARATOR
Intervention: No preoperative biliary decompression (Group B)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No preoperative biliary decompression (Group C)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 10
Study: 31484315

Group type: EXPERIMENTAL
Intervention: Wheat noodle ingestion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rice noodle ingestion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mung bean noodle ingestion
Number of subjects: 20
Study: 29762764

Group type: EXPERIMENTAL
Intervention: Ethanol 0.6 g/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ethanol 0.45 g/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 27395380

Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg/d (25 mg twice daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not treated with amitriptyline)
Number of subjects: 20
Study: 24631324

Group type: EXPERIMENTAL
Intervention: 1Hz rTMS over the SMA for 10 consecutive days
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 17
Study: 22700528

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT) for 24 hours
Number of subjects: 180

Group type: COMPARATOR
Intervention: Usual subcutaneous insulin for 24 hours
Number of subjects: 180

Group type: COMPARATOR
Intervention: Usual subcutaneous insulin
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT)
Number of subjects: 180

Group type: COMPARATOR
Intervention: 3-month functional outcome
Number of subjects: 180

Group type: COMPARATOR
Intervention: Death rate at 3 months
Number of subjects: 180

Group type: COMPARATOR
Intervention: Serious adverse events at 3 months
Number of subjects: 180